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Abstract
Objective: To review the demographic trends clinical spectrum, diasnosis, management and out come
of patients with vestibular Schwannoma and to identify areas where improvements are needed.
Methods: All pateints with vestibular schwannoma admitted to the Aga Khan University Hospital over
the past 11 years were reviewed retrospectively.
Results: The age range of majority of 22 patients analyzed, was 41-50 years (23%). Hearing loss was
the most common presenting symptom (96%). Other clinical features included cranial nerve palsies
(59%) and headache (55%). Fifty percent had signs of raised intracranial pressure. Neuroimaging
revealed “Stage IV b” (tumor distorting the brainstem and compressing the 4th ventricle) in 50% cases.
Neurosurgical intervention was carried out in 86%; mainly using the retrosigmoid approach.
Postoperative complications included facial nerve palsy in 13 (65%) and hydrocephalus in 5 (25%)
patients. Hearing determined clinically was preserved in three patients (14%). One patient died during
the inpatient stay.
Conclusion: Presentation of these patients is late and the outcome is poor (JPMA 51:63; 2001).
Introduction
Vestibular Schwannoma is a benign tumor arising from the schwann cells of the vestibular nerves,
usually within the internal auditory canal, It accounts for about eight percent of all intracranial tumors
and its incidence is estimated to be around one to five per 100,000 people per year1.
Hearing loss is the most common initial symptom of this tumor2-4. Usually there is a gradual hearing
reduction, but a sudden loss can occur or the hearing may be fluctuant1. Other symptoms include
tinnitus, dizziness, unsteadiness and a sensation of fullness in the ear. As the tumor enlarges, it begins
to impinge upon the trigeminal nerve, subsequently loss of corneal sensation and numbness or altered
sensation on the face and tongue develops. With larger tumors, symptoms of raised intracranial
pressure, involvement of the seventh and various caudal cranial nerves may occur1. Diagnosis is based
on clinical presentation and supporting evidence from various audiometric studies including brainstem
evoked response potentials and neuroimaging.
In the early twentieth century. the picture was one of the unmitigated gloom, with large tumors
presenting late and removed with such dreadful results that even to consider operating on a fit person
with a small tumor was regarded inappropriate5. With advances in diagnostic and surgical techniques,
the quest for preservation of the facial nerve and maintenance of useful hearing in certain cases has
become possible5.
This study presents the demographic trends, clinical spectrum, diagnostic modes, management
modalities and outcome of patients with vestibular schwannoma and to provide an authentic account of
the local pattern of disease and results of management and comparison of local results with current
international standards to identify the areas where improvements are needed.

Patients and Methods
This is a retrospective log review of all patients presenting with Vestibular Schwannoma over the last
11 years. Selection of patients was based on the ICD-9-CM code of classification. Diagnosis was made
on clinical presentation, imaging and confirmatory histopathology reports, where available in all
operated patients. All patients presenting with Vestibular Schwannoma over the last 11 years were
included in our study. Major variables reviewed were age, gender, symptom presentation, clinical
assessment, audiometry, laboratory and radiological investigation, tumor size at presentation,
modalities of treatment, postoperative complications and outcome.
Data extraction performas were prepared to retrieve information for this purpose. If patients were
admitted on multiple occasions with vestibular schwannoma, only the first admission was reviewed.
Patients on admission were classified into three clinical stages: Involvement of cranial nerve VIII alone
(Mild), multiple cranial nerve palsies (Moderate) and raised intracranial pressure, with or without
multiple cranial nerve palsies (Severe).
Radiological staging on computerized tomography/ magnetic resonance imaging followed this criteria5:
Tl: Intrameatal tumor, T2: Intra-extrameatal tumor, T3a: Filling the cerebellopontine cistern, T3b:
Reaching the brainstem, T4a: Compressing the brainstem and T4b: Distorting the brainstem and
compressing the 4th ventricle.
Statistical analysis
Data entry and analysis was carried out using the SPSS software (Release 8.0, standard version,
copyright SPSS Inc., 1989-97). All descriptive data is presented in the form of frequency tables and
figures. All percentages that are given in the text have been rounded up to the nearest whole number.
Results
Demographics
Twenty-two patients with vestibular schwannoma were admitted to Aga Khan University Hospital
between January 1989 and December 1999. Their mean age was 47 years (SD±l 3) and the male to
female ratio 1 : 1 .4. The age and gender distribution is summarized in Figure 1.

Majority of the patients (58%) were from Karachi City, 18% belonged to North West Frontier Province
(NWFP) and Afghanistan, 14% belonged to Balochistan and 5% each to Sind and Punjab.
Clinical Presentation
The major clinical features are shown in Figure 2.

Hearing loss, was present in 21 patients (96%), right side was involved in 10 patients (48%) and the left
in 11(52%) patients. The mean duration of hearing loss prior to presentation was 104 weeks. Amongst
the 19 patients (87%) in whom the character of the hearing loss was recorded, 17 (89%) had a history
of progressive hearing loss and 2 patients (11%) had an acute attack with total deafness. Twelve
patients (55%) reported to have headaches. Eighty two percent of these had episodic headaches while
9% each had continuous and morning headaches respectively. The mean duration of headaches was 37
weeks. Vertigo was reported in 11 patients (50%) with mean duration of 92 weeks. All of these patients
complained of a positional vertigo. Tinnitus was present in 6 patients (27%).
Amongst the signs, 13 patients (59%) had cranial nerve involvement. The frequency distribution of the
various cranial nerve palsies is summarized in Figure 3.

The trigeminal and facial nerves were the most commonly involved, with 10 patients in each group.
With respect to the trigeminal nerve, diminished or absent comeal reflex was identified in 7 (70%),
altered sensation of face in 6 (60%), weakness of muscle of mastication in 2 (20%) and neuralgia in
one (10%) patient.
Amongst those with facial nerve palsy, weakness of facial muscles was identified in eight patients
(80%), anesthesia of external auditory canal in two (20%) and taste impairment in one (10%).
Cerebellar signs were present in 11 patients (50%). Nine patients (81%) had gait disturbances, 4 (36%)
had nystagmus and 2 (18%) had ataxia.
Clinically, raised intra cranial pressure was suspected in 12 patients. Clinical features pointing towards
raised intracranial pressure were headaches in all, nausea / vomiting in 9 patients (75%), papilledema in
three (25%) and drowsiness in another three (25%) cases. Two patients (9%) had some peripheral
motor deficit while one (5%) had both motor and sensory deficits. All patients were categorized into
mild, moderate and severe presentations. Six patients (27%) had a mild,. 5 (23%) had moderate and
11(50%) had a severe presentation.
One patient (5%) gave a history of head trauma prior to his symptoms. None of the patients had a
recorded positive family history for any kind of malignancy.
Comorbids were identified in nine of our patients (41%). Amongst these, 6 patients (66%) had
hypertension, 4 (44%) diabetes mellitus and one (11%) each had asthma and ischemic heart disease.
Only one patient (11%) had neurofibromatosis with a unilateral tumor. A total of three patients had
multiple comorbids.
Diagnosis
Audiometric studies were performed in 5 patients (23%).On pure tone audiometry (PTA), all had a
“dead ear”. Brainstem evoked response audiometry was done in two patients (40%). Latency of
response waves and interauricular latency of greater than 0.2 milliseconds was identified in both cases.
Diagnostic imaging was performed in 21 patients, which included computed tomography in 11 (52%)
and magnetic resonance imaging in 7 (33%) patients. One patient had CT and roentgenography (4%)
and 2 (10%) had both CT and MRI done.
The size of the tumor, as determined by imaging, was categorized into less than 2x3 cms and greater
than 2x3 cms. Six patients (29%) had a tumor less than 2x3 cms while 15 (71%) had a larger sized

tumor. Radiological staging, as defined earlier, has been summarized in Table 1.

Amongst the 18 patients in which staging was recorded, majority (50%) had a stage T4b tumor.
Imaging reports commented on hydrocephalus in 19 patients; 9 patients (47%) were reported to have
hydrocephalus. The location ofjugular foramen in relation to the tumor was not reported in any of the
radiology reports.
Surgical management alone was done in 19 patients (86%) and a combination of surgery and
radiotherapy was done in two patients (9%). One patient (5%) was managed conservatively.
Suboccipital! retrosigmoid approach was most favored, being performed in 19 patients (91%). In one
patient (5%) tumor removal was by the translabrynthine approach. In another patient only VP shunting
procedure was performed for symptomatic relief of hydrocephalus.
Intraoperatively, the tumor was found to be adherent to adjacent tissues in 11 (5 5%), vascular in lO
(50%), encapsulated in 4 (20%) and hemorrhagic in 3 (15%) patients. In one patient each, the tumor
was found to be cystic and necrotic, respectively. All excised tumors sent for histopathology were
schwannomas. None of the samples revealed any form of malignant change.
Postoperatively, radiological imaging was done in 10 patients (48%) only. Amongst these, 3 (30%) had
a complete resection and 7 (70%) showed a partial / subtotal resection of tumor. Hearing preservation
determined clinically was found to be intact in 3 patients (14%). A variety of postoperative
complications were identified; these have been listed in Table 2.

Amongst the postoperative complications, facial nerve palsy was identified in 13 patients (65%) and
hydrocephalus in 5 (25%). One patient (5%) died during his inpatient stay in the hospital.
Discussion
This study has brought forth many important aspects of vestibular schanommas particularly those
which revolve around a late presentation and an advanced staged tumor. The fact that only 22 patients
surfaced to the AKUH in the last 11 years can possibly be explained by the inaccessibility to the health
care system available to a majority of our population. Screening and referral systems are also
inadequate. These factors give an erroneous picture of true incidence of this tumor next to negligible.
Other Western studies in contrast have enrolled more than 1000 patients in a time frame of 16 years6.
In this series of 22 patients the mean age, range and the male to female ratio is similar to other reported
series6-9, but vestibular schwannoma were associated with pregnancy10. The association between
ethnicity and the incidence of this tumor has not yet been reported. In this series 18% of patients
belonged to the NWFP and Afghanistan, indicating to establish this pattern a further prevalence study is
needed.
The symptomatology in this series is consistent with Western data. The proportion of patients with
hearing loss and dizziness/vertigo are similar to other studies1-3,5,9 which report a range of 80-96% for
hearing loss and 37-61% for dizziness which is similar to this study where 96% had hearing loss and
50% dizziness. However, 27% of patients complained of tinnitus in contrast to 40-90% reported by
others1,6,9. Investigators revealed an inverse association between tinnitus and tumor extension; patients
with smaller tumors having higher rates of tinnitus6. Many more patients (55%) in this series
complained of headaches compared to 5-30% reported by others1. Both these findings can solely be

attributed to a late presentation and a larger tumor size. Two of patients presented with sudden hearing
loss. Vestibular schwannomas should be considered as a differential for this symptom11,12.
With the expansion of tumor in the cerebellopontine angle, other cranial nerves and structures are
frequently involved. The sensory part of the trigeminal nerve is usually the first cranial nerve (CN),
other than CN Vlll3. This manifests as diminished or absent corneal reflexes and anesthesia of the
ipsilateral face. Continued growth shows involvement of caudal cranial nerves. CN VII shows
resilience even under extreme pressure and stretching with the sensory division getting involved first3.
Other series have reported about 20% for CN VS and 6-33% for CN Vll1,6,9. This series shows an
equal number of patients with some form of trigeminal and facial nerve involvement (45% each). Also,
in contrast to other settings where signs of raised intracranial pressure (RICP) rarely bring the patient to
the hospital, 55% of patients in this study had clinical evidence of RICP at the time of admission. These
findings because of high rate (>50%) of large tumors and late referrals. These large tumors caused
brain stem compress ion and obstructive hydrocepha lus.
Head CT/MRI has become the “gold standard” for diagnosing such tumors. In today’s cost-containment
environment, it is impossible for every patient with nonspecific complaints to undergo these expensive
tests. Hence it is important to use preliminary screening tests with a high degree of sensitivity for
retrocochlear pathology3. Unfortunately, more than 50% of our patients presented as neurosurgical
emergencies with raised intracranial pressure. This explains the fact that only 23% of our patients
underwent basic audiometric tests. All of these had a “dead ear” and hence speech discrimination could
not be assessed. BERA is regarded to be a highly sensitive screening test3,7,13-5. Similarly the value of
a plain X-ray film of the internal auditory canal should not be underestimated. Accuracy of good
quality plain film is approximately 90%3. As little as one-millimeter difference between the two
internal auditory canals may be significant3. It is, therefore, recommended that these cheaper screening
modalities should be considered first in most patients. With an abnormality in any one of these, CT or
MRI should be performed next. However, in highly suspected patients, preliminary tests need to be
bypassed. CT/MRI are important to stage the tumor and assessing the prognosis4. Moreover, it guides
decisions regarding surgical management. The angle of petrous bones helps in positioning the patient
and the extent of cerebeltar manipulation4. In addition, the occurrence of a high jugular bulb is not
infrequent. Preoperative neuroimaging prevents inadvertent damage to the bulb while the posterior wall
of the internal auditory canal is drilled4. Therefore, these findings should specifically be looked for and
should be reported by the radiologists.
Treatment options considered in a patient with vestibular schwannoma are surgery, radiation and
observation1. Owing to lack of radiation facilities in our part of the world, this has not yet received
much recognition. The standard treatment therefore remains surgical excision, using one of the several
approaches: including posterior fossa, middle fossa or translabrynthine. Most of our patients (91%)
underwent the posterior fossa (suboccipital /retrosigmoid) approach, which is commonly used by most
neurosurgeons4. Posterior and middle cranial fossa approaches can offer hearing preservation. Posterior
fossa approach preserves hearing ranging from 6-58% and that of middle fossa from 3 1-59%16. A
study from Yale School of Medicine has established that a tumor of 1.5 cms or less has a 50% chance
of hearing preservation16. The translabrynthine approach, which was offered in one patient, has the
advantage of better identification and preservation of CN VII1,4,6,16. However, with this approach,
deafness is inevitable.
The management of vestibular schwannoma in local setting is rnainly for saving life in majority of the
patients. Facial palsy was recorded in 65% of the postoperative patients and hearing could only be
preserved in 14%. Preservation of facial nerve and hearing and reduction in the various postoperative
complications can only be made possible with early detection of the tumor. Good access to health care

system. etlicient screening and early referral are pre-requisites for achievement of these aims.
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